El propósito de esta nota informativa es
proporcionar información a las organizaciones de la sociedad civil venezolana,
las comunidades afectadas y sus aliados, sobre qué esperar con respecto a la
gobernanza, la toma de decisiones y la supervisión de esta subvención del Fondo
Mundial sin un MCP.… Read more
In October 2019, at the sixth Global Fund replenishment conference in Lyon, France, donors pledged over US $14 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria for the 2020-2022 funding cycle.
Meaningful engagement of key populations is central to the way the Global Fund works.… Read more
10 October 2019 (Lyon, France) – Today the Global Fund to Fight AIDS, TB and Malaria held its historic 6th Replenishment Conference – an international gathering of representatives from across the Global Fund partnership: donor governments, the private sector, implementing country governments, civil society and communities impacted by the three diseases.… Read more
ICASO, Global Development One and ICAD applaud the US Senate and House of Representatives for recommending funding of at least $1.56 billion per year for the next three years to the Global Fund to continue its fight against three of the world’s most devastating communicable diseases.
19 September 2019 (Toronto, ON) – The US Senate Appropriations Committee posted the State, Foreign Operations, and Related Programs fiscal year 2020 funding bill on September 18 recommending a 15.6… Read more
Are you engaged in the community response to HIV and want to help influence global policy? Founded in 1991, ICASO’s Mission is to mobilize and support diverse community organizations and networks to create and sustain effective responses to HIV. Our global advocacy and community development endeavors are undertaken with a Vision of ending the AIDS epidemic through universal access to HIV prevention, treatment, care and support under a human rights framework.
ICASO is guided by its 2017-2020 Strategic Plan Evidence, Alliances, Advocacy: Sustaining community responses to HIV.… Read more